Atreca, Inc. EBT

EBT of BCEL for past 10 years: annual, quarterly and twelve month trailing (TTM) including EBT growth rates and interactive chart. Earnings before tax (EBT) measures a company's financial performance. Its calculation is revenue minus expenses, excluding taxes. EBT is a line item on a company's income statement. It shows company earnings with the cost of goods sold (COGS), interest, depreciation, general and administrative expenses, and other operating expenses deducted from gross sales.

Highlights and Quick Summary

  • EBT for the quarter ending September 30, 2022 was $-23.1 Million (a -17.28% decrease compared to previous quarter)
  • Year-over-year quarterly EBT decreased by -21.88%
  • Annual EBT for 2021 was $-109 Million (a 26.63% increase from previous year)
  • Annual EBT for 2020 was $-86.3 Million (a 27.93% increase from previous year)
  • Annual EBT for 2019 was $-67.5 Million (a 77.86% increase from previous year)
  • Twelve month EBT ending September 30, 2022 was $-105 Million (a -3.92% decrease compared to previous quarter)
  • Twelve month trailing EBT decreased by -3.65% year-over-year
Trailing EBT for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
$-105 Million $-110 Million $-108 Million $-109 Million
Visit stockrow.com/BCEL for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EBT of Atreca, Inc.

Most recent EBTof BCEL including historical data for past 10 years.

Interactive Chart of EBT of Atreca, Inc.

Atreca, Inc. EBT for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 – $-23.06 $-27.88 $-24.88 –
2021 $-29.52 $-27.36 $-26.67 $-25.78 $-109.33
2020 $-23.01 $-22.93 $-19.98 $-20.42 $-86.33
2019 $-20.11 $-15.87 $-17.92 $-13.58 $-67.48
2018 – – $-9.63 $-8.67 $-37.94
2017 – – – – $-27.52

Business Profile of Atreca, Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com